Second round of financing of SAW Instrument with KI Kapital, HTGF and KfW successfully completed
SAW Instruments has completed in early February its second financing round of one million EUR and is aiming to reach break-even in fiscal year 2012. “The funds will be invested in particular in the expansion of sales & marketing activities and extending our product portfolio.” says Managing Director Sabine Bois.
After an extremely positive development of the company in 2010, the management is very pleased that the KfW joined as new investor. “We have worked together very well with KI and the HTGF in the last year and are pleased to have found another strong partner with the KfW to help us achieve our strategic objectives.”
This year SAW Instruments will expand its market presence in Central Europe and make its first steps into the U.S. market. In addition, next to the biosensor sam5 another instrument – the sam5 pro – will be introduced in the second quarter to address besides the research market, additional applications especially within quality assurance. The samX to be launched in September 2011 will provide the customer with unmatched flexibility for sample loading and parallel analyses. “The sam5 pro and the samX represent an important step towards meeting the needs of the pharmaceutical and biotech industries. We believe this product portfolio gives us a strong position in our target markets. ” adds Managing Director Dr. Markus Perpeet.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
